西点药业
(301130)
| 流通市值：14.65亿 | | | 总市值：20.39亿 |
| 流通股本：5802.81万 | | | 总股本：8080.40万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 66,705,459.25 | 225,491,234.57 | 170,495,925.88 | 114,087,002.92 |
| 营业收入 | 66,705,459.25 | 225,491,234.57 | 170,495,925.88 | 114,087,002.92 |
| 二、营业总成本 | 52,927,049.86 | 196,077,638.52 | 143,337,161.46 | 96,053,370.7 |
| 营业成本 | 14,644,080.71 | 44,500,700.58 | 31,061,292.61 | 20,268,564.98 |
| 税金及附加 | 1,510,342.14 | 5,532,870.35 | 4,144,419.58 | 2,792,379.66 |
| 销售费用 | 28,662,399.27 | 119,827,974.61 | 90,281,915.56 | 61,482,878.63 |
| 管理费用 | 5,954,810.52 | 23,010,606.74 | 16,605,939.93 | 11,209,489.62 |
| 研发费用 | 4,152,708.3 | 8,699,811.69 | 5,227,257.77 | 3,058,966.49 |
| 财务费用 | -1,997,291.08 | -5,494,325.45 | -3,983,663.99 | -2,758,908.68 |
| 其中:利息费用 | 21,892.82 | 46,941.44 | - | - |
| 其中:利息收入 | 2,028,659.25 | 5,571,937.22 | 4,026,239.33 | 2,775,629.71 |
| 加:公允价值变动收益 | 547,041.59 | 3,147,565.51 | 4,318,800.29 | 2,816,097.09 |
| 加:投资收益 | 472,006.47 | 7,773,219.11 | 4,491,705.35 | 3,317,046.25 |
| 资产处置收益 | - | 1,868,842.63 | - | - |
| 资产减值损失(新) | -71,412.16 | -769,510.01 | -696,817.39 | -734,338.56 |
| 信用减值损失(新) | -707,006.84 | 511,813.05 | -197,185.97 | -65,839.46 |
| 其他收益 | 2,286,196.72 | 13,705,862.13 | 12,885,308.95 | 12,042,078.76 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 16,305,235.17 | 55,651,388.47 | 47,960,575.65 | 35,408,676.3 |
| 加:营业外收入 | - | 3,000,000 | - | - |
| 减:营业外支出 | 203,207.96 | 338,732.7 | 147,240.79 | 119,561.95 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 16,102,027.21 | 58,312,655.77 | 47,813,334.86 | 35,289,114.35 |
| 减:所得税费用 | 2,059,183.54 | 7,810,236.97 | 6,519,306.61 | 4,965,824.89 |
| 六、净利润 | 14,042,843.67 | 50,502,418.8 | 41,294,028.25 | 30,323,289.46 |
| 持续经营净利润 | 14,042,843.67 | 50,502,418.8 | 41,294,028.25 | - |
| 归属于母公司股东的净利润 | 14,042,843.67 | 50,502,418.8 | 41,294,028.25 | 30,323,289.46 |
| (一)基本每股收益 | 0.17 | 0.63 | 0.51 | 0.38 |
| (二)稀释每股收益 | 0.17 | 0.63 | 0.51 | 0.38 |
| 九、综合收益总额 | 14,042,843.67 | 50,502,418.8 | 41,294,028.25 | 30,323,289.46 |
| 归属于母公司股东的综合收益总额 | 14,042,843.67 | 50,502,418.8 | 41,294,028.25 | 30,323,289.46 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-26 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |